retatrutide weight loss clinical trial results A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing and diabetes Phase III retatrutide study demonstrates

Disrupted intestinal permeability is closely associated with dysbiosis, and there is reason to think that repairing the mucosal barrier creates a more hospitable environment for a healthy microbial community

Start Your Journey Consultation Meet with our physician to discuss your longevity goals and determine if Epithalon therapy aligns with your health objectives

Which raises an interesting question: is the problem always the amount of fuel available - or could it be how efficiently that fuel is being used

Optional monthly boost

If you agree to this procedure, you may need to stop taking certain medications and fast for eight hours beforehand

however, effective strategies to selectively eliminate senescent endothelial cells and restore vascular function remain lacking